![](/img/cover-not-exists.png)
Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)
Abdullayev, Emin, Kilic, Omer, Bozan, Gurkan, Kiral, Eylem, Iseri Nepesov, Merve, Dinleyici, Ener CagriJournal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2019.1711298
Date:
February, 2020
File:
PDF, 1.12 MB
2020